Alexander Fleming

Born on August 6, 1881, in Lochfield, Scotland, Alexander Fleming's early life on a farm instilled in him a practical approach to observation. After serving in the First World War, where he witnessed firsthand the devastating impact of infected wounds, Fleming returned to his research at St. Mary's Hospital Medical School in London.

His focus was on understanding the body's natural defenses against bacteria. This led to his significant discovery in 1922 of lysozyme, an enzyme found in bodily fluids that possesses antibacterial properties. While lysozyme proved effective against certain bacteria, its limitations meant it couldn't combat the more dangerous pathogens responsible for widespread disease.

This early success, however, honed his skills in isolating and identifying antimicrobial agents, setting the stage for his most famous discovery.

Fleming's legendary discovery of penicillin in 1928 was a classic example of scientific serendipity, combined with his keen observational powers. Returning from a holiday, he found that a petri dish containing Staphylococcus bacteria had been contaminated by a mold, later identified as Penicillium rubens. Crucially, he observed a clear zone around the mold where the bacteria had been lysed, or destroyed.

This was not merely an observation of mold growth; it was the identification of a potent antibacterial substance produced by the mold. Fleming meticulously cultured the mold and extracted the active substance, which he named penicillin. He conducted further experiments, demonstrating its effectiveness against a range of pathogenic bacteria while noting its apparent harmlessness to human cells, a critical characteristic for a therapeutic agent.

He published his findings in 1929, but the challenge of isolating and purifying penicillin in sufficient quantities for clinical use remained.

Despite Fleming's initial publication, penicillin remained largely a laboratory curiosity for over a decade due to the difficulties in producing it in large amounts. It was the urgent need for effective treatments during World War II that spurred renewed efforts. A team at Oxford University, led by Howard Florey and Ernst Chain, revisited Fleming's work and developed methods for large-scale production and purification of penicillin.

Their clinical trials in the early 1940s demonstrated its remarkable efficacy in treating severe bacterial infections, transforming the prognosis for countless patients, particularly soldiers with battlefield wounds. This breakthrough earned Fleming, Florey, and Chain the Nobel Prize in Physiology or Medicine in 1945, recognizing their collective contribution to a medical revolution. Penicillin became the first widely effective antibiotic, dramatically reducing mortality rates from previously deadly diseases like pneumonia, sepsis, and syphilis.

Sir Alexander Fleming, knighted in 1944, passed away on March 11, 1955, but his impact on global health is immeasurable. His discovery of penicillin not only saved millions of lives directly but also inaugurated the era of antibiotics. This opened up new avenues for treating infectious diseases, enabling advancements in surgery, organ transplantation, and chemotherapy, all of which rely on controlling bacterial infections.

Fleming's work highlighted the potential of naturally occurring compounds as therapeutic agents and inspired the subsequent search for other antibiotics, leading to the development of a vast arsenal of drugs that continue to combat bacterial pathogens. His recognition in TIME's list of the 100 Most Important People of the 20th century and numerous other accolades underscore his status as one of history's most influential scientists, whose accidental discovery fundamentally reshaped human health and longevity.